文献速递神经MR

标准化相对CBV在复发高级别胶质瘤中量化区域组织学肿瘤负荷的性能:与基于图像定位立体定向活检的归一化相对CBV比较

Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-03-12

本研究纳入38例既往治疗的高级别胶质瘤患者,获取112个图像定位活检标本,比较标准化相对CBV与归一化相对CBV在预测组织学肿瘤含量(0%-100%)及二元阈值(≥50%、≥80%)下的性能。结果显示标准化相对CBV性能与归一化相似,分数肿瘤负荷相关性最高(标准化r=0.66,归一化r=0.63),标准化方法无需用户定义参考组织,有助于工作流程优化和共识方法学。

要点

  • 标准化相对CBV无需用户定义参考组织,性能与归一化相对CBV相似。
  • 分数肿瘤负荷与组织学肿瘤含量相关性最高(标准化r=0.66,归一化r=0.63)。
  • 预测≥50%肿瘤时中位相对CBV的AUC最高(归一化0.87,标准化0.86)。

关键影像表现/征象

  • 计算每个活检标本的组织学肿瘤含量百分比(0%-100%)及治疗后放射效应。
  • 测量空间匹配的归一化和标准化相对CBV指标(均值、中位数)及分数肿瘤负荷。

诊断标准与关键数值

  • 标准化相对CBV分数肿瘤负荷与组织学肿瘤含量(0%-100%)的Pearson相关系数r=0.66(P<.001),归一化为r=0.63(P<.001)。
  • 预测≥50%肿瘤时,中位相对CBV的AUC最高:归一化=0.87,标准化=0.86。
  • 预测≥80%肿瘤时,分数肿瘤负荷的AUC最高:归一化=0.77,标准化=0.80。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Perfusion MR imaging measures of relative CBV can distinguish recurrent tumor from posttreatment radiation effects in high-grade gliomas. Currently, relative CBV measurement requires normalization based on user-defined reference tissues. A recently proposed method of relative CBV standardization eliminates the need for user input. This study compares the predictive performance of relative CBV standardization against relative CBV normalization for quantifying recurrent tumor burden in high-grade gliomas relative to posttreatment radiation effects.

MATERIALS AND METHODS: We recruited 38 previously treated patients with high-grade gliomas (World Health Organization grades III or IV) undergoing surgical re-resection for new contrast-enhancing lesions concerning for recurrent tumor versus posttreatment radiation effects. We recovered 112 image-localized biopsies and quantified the percentage of histologic tumor content versus posttreatment radiation effects for each sample. We measured spatially matched normalized and standardized relative CBV metrics (mean, median) and fractional tumor burden for each biopsy. We compared relative CBV performance to predict tumor content, including the Pearson correlation (r), against histologic tumor content (0%-100%) and the receiver operating characteristic area under the curve for predicting high-versus-low tumor content using binary histologic cutoffs (≥50%; ≥80% tumor).

RESULTS: Across relative CBV metrics, fractional tumor burden showed the highest correlations with tumor content (0%-100%) for normalized (r = 0.63, P < .001) and standardized (r = 0.66, P < .001) values. With binary cutoffs (ie, ≥50%; ≥80% tumor), predictive accuracies were similar for both standardized and normalized metrics and across relative CBV metrics. Median relative CBV achieved the highest area under the curve (normalized = 0.87, standardized = 0.86) for predicting ≥50% tumor, while fractional tumor burden achieved the highest area under the curve (normalized = 0.77, standardized = 0.80) for predicting ≥80% tumor.

CONCLUSIONS: Standardization of relative CBV achieves similar performance compared with normalized relative CBV and offers an important step toward workflow optimization and consensus methodology.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Hoxworth JM, Eschbacher JM, Gonzales AC, et al. Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies. AJNR Am J Neuroradiol. 2020. PMID: 32165359. doi:10.3174/ajnr.A6486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。